Ascension Healthcare Announces Positive Data from Phase 2 Study of SelectAte in Severe Haemophilia A Patients with inhibitors
December 12, 2022 07:00 ET
|
Ascension
Ascension Healthcare Announces Positive Data from Phase 2 Study of SelectAte in Severe Haemophilia A Patients with inhibitors Results showed co-administration of PEGLip with factor VIII led to an...
Ascension Healthcare Announces Positive Data from Phase 2 Study of XLR8 in Severe Haemophilia A Patients
December 12, 2022 07:00 ET
|
Ascension
Ascension Healthcare Announces Positive Data from Phase 2 Study of XLR8 in Severe Haemophilia A Patients Injection of an adjuvant PEGylated lipid (PEGLip) following a normal dose of standard...
FlexiSEQ™ Max Strength wins Highly Commended in the Most Valuable Product Awards 2022
November 25, 2022 07:00 ET
|
Ascension
PRESS RELEASE FlexiSEQ™ Max Strength wins Highly Commended in the Most Valuable Product Awards 2022 LONDON, 25 November 2022 – Ascension Healthcare plc (“Ascension” or the “Company”), a...
Ascension Healthcare to Present Positive Phase 2 Data on Two Haemophilia Programmes at the 64th American Society of Hematology Annual Meeting
November 03, 2022 09:30 ET
|
Ascension
Ascension Healthcare to Present Positive Phase 2 Data on Two Haemophilia Programmes at the 64th American Society of Hematology Annual Meeting Data demonstrates the potential of SelectAte and XLR8...
Ascension Launch Takes Corporate Real Estate to New Heights
April 21, 2022 09:00 ET
|
Ascension
NEW YORK, New York, April 21, 2022 (GLOBE NEWSWIRE) -- Mike James of James Capital Advisors and Chelsea Mandel have partnered to launch Ascension, a contemporary commercial real estate advisory firm...
Ascension Healthcare plc: Business Update
November 29, 2021 02:00 ET
|
Ascension
Ascension Healthcare plc Business Update ~ Progress across Haemophilia clinical programmes and further expansion of Consumer Healthcare business~ LONDON, November 29, 2021 – Ascension Healthcare...
Ascension provides a positive update on its intellectual property portfolio
October 25, 2021 07:00 ET
|
Ascension
Ascension provides a positive update on its intellectual property portfolio - Key patents granted by the European Patent Office - LONDON, October 25, Ascension Healthcare plc (“Ascension” or the...
Appointment of Professor Trevor M Jones, CBE FMedSci, as Non-Executive Director
September 20, 2021 07:00 ET
|
Ascension
PRESS RELEASE Appointment of Professor Trevor M Jones, CBE FMedSci, as Non-Executive Director LONDON, September 20, 2021 – Ascension Healthcare plc (“Ascension” or “the Company”), a clinical-stage...
Ascension Healthcare announces partnership with Grand Meadows to launch joint support technology NANOFLEX in US Animal Healthcare market
April 15, 2021 08:00 ET
|
Ascension
PRESS RELEASE Ascension Healthcare announces partnership with Grand Meadows to launch joint support technology NANOFLEX in US Animal Healthcare market LONDON, April 15 2021 – Ascension Healthcare...
Appointment of Ben Vertannes as Head of Global Marketing
March 08, 2021 02:00 ET
|
Ascension
PRESS RELEASE Appointment of Ben Vertannes as Head of Global Marketing LONDON, March 8, 2021 – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage pharmaceutical company...